RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that is pioneering the use of robotics and flexible instruments to improve minimally invasive surgery, today announced its operating and financial results for the first quarter 2015. Operating Highlights Announces Completion of GLP Studies SurgiBot system FDA 510(k) Submission Expected in June 2015 “We are pleased with our progress in the first quarter and to have successfully completed
| < Prev | Next > |
|---|
